(S)-2-(3-methoxypropyl)-1,1-dioxido-6-(N-tosylsulfamoyl)-3,4-dihydro-2H-thieno[3,2-e][1,2]thiazin-4-yl 4-methylbenzenesulfonate-D4; 1-((4-((4-fluoro-2-methyl-1H-indol-5-yl)oxy)-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yl)oxy)propan-2,3,3,3-d4-2-ol
Brivanib-d4 is a fully characterized chemical compound used as a reference standard of API Brivanib. The standard offered is compliant with regulatory guidelines. Brivanib-d4 is used for analytical method development, method validation (AMV), and Quality Controlled (QC) applications during synthesis and formulation stages of drug development and serves as a reference standard for traceability against pharmacopeial standards (USP or EP). Axios Research products are intended for analytical purposes only and are not for human use. CAS -
